The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often at Seed and in Biotech.
Venture capitalkerna.vcRounds from 2026-09-29 to 2026-10-12
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Undecimal Bio A spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics | Seed Verified against 1 of 20 sources | $18M | 2026-10-12 | [ PART ] |
Rouge Therapeutics A provider of first-in-class disease-modifying therapies designed to restore vascular integrity | Series A |
| $58M |
| 2026-10-06 |
| [ PART ] |
Aptadir Therapeutics A preclinical biotech company developing a new class of RNA therapeutics | Seed Verified against 1 of 40 sources | $44.7M | 2026-09-29 | [ PART ] |